|
1
|
Treatment of hypertension with propranolol.
|
Br Med J
|
1969
|
8.21
|
|
2
|
Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison.
|
Br Med J
|
1968
|
3.89
|
|
3
|
Propranolol in the therapy of angina pectoris.
|
Am J Cardiol
|
1966
|
3.28
|
|
4
|
Propranolol in hypertension.
|
Am J Cardiol
|
1966
|
2.28
|
|
5
|
Preoperative and operative management of patients with phaeochromocytoma.
|
Br Med J
|
1967
|
2.22
|
|
6
|
Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma.
|
Am J Cardiol
|
1966
|
1.95
|
|
7
|
The clinical pharmacology of beta adrenergic blocking drugs.
|
J R Coll Physicians Lond
|
1976
|
1.94
|
|
8
|
Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise.
|
Br Heart J
|
1971
|
1.85
|
|
9
|
Labetalol in long-term treatment of hypertension.
|
Br J Clin Pharmacol
|
1976
|
1.73
|
|
10
|
Interactions between sympathomimetic amines and antidepressant agents in man.
|
Br Med J
|
1973
|
1.68
|
|
11
|
Modification by monoamine oxidase inhibitors of the effect of some sympathomimetics on blood pressure.
|
Br Med J
|
1967
|
1.68
|
|
12
|
Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.
|
Clin Sci Mol Med Suppl
|
1975
|
1.66
|
|
13
|
Blood levels of practolol following intravenous administration.
|
Br J Pharmacol
|
1970
|
1.61
|
|
14
|
Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
|
Br J Clin Pharmacol
|
1976
|
1.53
|
|
15
|
Beta-adrenergic receptor blocking drugs in angina pectoris.
|
Drugs
|
1974
|
1.46
|
|
16
|
Preliminary studies of the pharmacological effects of 5-[1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)-ethyl] salicylamide (AH 5158) in man.
|
Clin Sci
|
1971
|
1.41
|
|
17
|
Relationships between industry and units of clinical pharmacology.
|
Br J Clin Pharmacol
|
1978
|
1.39
|
|
18
|
Proceedings: Preliminary observations on the human pharmacology of I.C.I. 66082 in normal volunteers.
|
Br J Pharmacol
|
1973
|
1.29
|
|
19
|
The treatment of hypertension by beta adrenergic blocking drugs.
|
Angiologica
|
1966
|
1.25
|
|
20
|
Clinical pharmacology: function, organisation, and training.
|
Lancet
|
1971
|
1.19
|
|
21
|
The distribution of catecholamines between platelets and plasma in normal human subjects.
|
Clin Sci (Lond)
|
1985
|
1.14
|
|
22
|
The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.
|
Br J Clin Pharmacol
|
1978
|
1.11
|
|
23
|
Clinical pharmacology of labetalol.
|
Br J Clin Pharmacol
|
1979
|
1.09
|
|
24
|
Adrenoceptor blockade of the circulatory responses to intravenous isoproterenol.
|
Clin Pharmacol Ther
|
1978
|
1.08
|
|
25
|
Pharmacological basis for antihypertensive effects of intravenous labetalol.
|
Br Heart J
|
1977
|
1.08
|
|
26
|
Variation in the modification of cardiovascular responses by sympathetic inhibitory drugs.
|
Proc R Soc Med
|
1969
|
1.06
|
|
27
|
Post-marketing drug surveillance.
|
Br J Clin Pharmacol
|
1978
|
1.05
|
|
28
|
The beta-adrenergic blockade withdrawal phenomenon.
|
J Cardiovasc Pharmacol
|
1983
|
1.04
|
|
29
|
The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: the effect on heart rate and the electrocardiogram.
|
Postgrad Med J
|
1970
|
1.03
|
|
30
|
Once daily treatment of mild to moderate hypertension with xipamid: a controlled study.
|
Br J Clin Pharmacol
|
1977
|
1.03
|
|
31
|
Overdosage with beta-adrenergic blocking agents.
|
Adverse Drug React Acute Poisoning Rev
|
1984
|
1.03
|
|
32
|
Three cases of severe hypertension controlled with propranolol.
|
Proc R Soc Med
|
1968
|
1.03
|
|
33
|
The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.
|
Br J Clin Pharmacol
|
1982
|
1.02
|
|
34
|
beta Adrenergic blocking drugs.
|
Pharmacol Ther
|
1980
|
1.01
|
|
35
|
Postjunctional selectivity of alpha-blockade with prazosin, trimazosin, and UK-33,274 in man.
|
J Cardiovasc Pharmacol
|
1982
|
0.99
|
|
36
|
Propranolol in the treatment of angina: a review.
|
Postgrad Med J
|
1976
|
0.98
|
|
37
|
Isoprenaline-induced tachycardia in man.
|
Br J Pharmacol
|
1972
|
0.97
|
|
38
|
Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.
|
Br J Clin Pharmacol
|
1990
|
0.96
|
|
39
|
Circulatory effects of noradrenaline and adrenaline before and after labetalol.
|
Br J Clin Pharmacol
|
1979
|
0.93
|
|
40
|
Fish oils and cardiovascular disease.
|
BMJ
|
1995
|
0.93
|
|
41
|
Long-term treatment of hypertension with labetalol.
|
Br J Clin Pharmacol
|
1979
|
0.92
|
|
42
|
Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
|
J Cardiovasc Pharmacol
|
1987
|
0.92
|
|
43
|
Circulatory and alpha-adrenoceptor blocking effects of phentolamine.
|
Br J Clin Pharmacol
|
1978
|
0.91
|
|
44
|
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
|
Drugs
|
1984
|
0.90
|
|
45
|
Propranolol as an antihypertensive agent.
|
Am Heart J
|
1970
|
0.89
|
|
46
|
Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension.
|
Br J Clin Pharmacol
|
1982
|
0.88
|
|
47
|
Haemodynamic studies in hypertensive patients treated by oral proranolol.
|
Br Heart J
|
1970
|
0.87
|
|
48
|
The effect of graded doses of practolol on the tachycardia induced by isoprenaline, Valsalva's manoeuvre and exercise.
|
Br J Pharmacol
|
1970
|
0.86
|
|
49
|
Concurrent antagonism of isoproterenol and norepinephrine after labetalol.
|
Clin Pharmacol Ther
|
1978
|
0.86
|
|
50
|
The effect of intrinsic sympathomimetic activity on beta-receptor responsiveness after beta-adrenoceptor blockade withdrawal.
|
Br J Clin Pharmacol
|
1982
|
0.86
|
|
51
|
Activation and blockade of beta adrenoceptors in common cardiac disorders.
|
Br Med Bull
|
1973
|
0.85
|
|
52
|
Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
|
Drugs
|
1988
|
0.85
|
|
53
|
Beta-adrenoceptor-blocking agents in the management of hypertension.
|
Cardiology
|
1979
|
0.84
|
|
54
|
Trace element and vitamin deficiency in alcoholic and control subjects.
|
Alcohol Alcohol
|
1991
|
0.84
|
|
55
|
The use of beta adrenergic blocking drugs in cardiovascular disease.
|
Scott Med J
|
1976
|
0.83
|
|
56
|
Uses of beta-adrenoceptor blocking drugs.
|
J R Coll Physicians Lond
|
1976
|
0.82
|
|
57
|
Beta receptor antagonism in hypertension; comparison with the effect of adrenergic neurone inhibition on cardiovascular responses.
|
Int Z Klin Pharmakol Ther Toxikol
|
1970
|
0.82
|
|
58
|
Interactions between catecholamines and tricyclic and monoamine oxidase inhibitor antidepressive agents in man.
|
Br J Pharmacol
|
1971
|
0.82
|
|
59
|
Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers.
|
Br J Clin Pharmacol
|
1990
|
0.82
|
|
60
|
The additional properties of beta adrenoceptor blocking drugs.
|
J Cardiovasc Pharmacol
|
1986
|
0.81
|
|
61
|
Withdrawal phenomena after atenolol and bopindolol: hormonal changes in normal volunteers.
|
Br J Clin Pharmacol
|
1990
|
0.81
|
|
62
|
Stimulus-induced release of endogenous catecholamines from human washed platelets.
|
Clin Sci (Lond)
|
1986
|
0.80
|
|
63
|
Platelet catecholamines and platelet function in normal human subjects.
|
Clin Sci (Lond)
|
1987
|
0.80
|
|
64
|
The effect of AH 5158, pindolol, propranolol, D-propranolol on acute exercise tolerance in angina pectoris.
|
Br J Pharmacol
|
1973
|
0.79
|
|
65
|
Xipamide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
|
Drugs
|
1985
|
0.79
|
|
66
|
Self-poisoning with beta-blockers.
|
Br Med J
|
1978
|
0.79
|
|
67
|
Pharmacologic aspects of intrinsic sympathomimetic activity in beta-blocking drugs.
|
Am J Cardiol
|
1987
|
0.79
|
|
68
|
Hypotensive drugs.
|
Practitioner
|
1968
|
0.79
|
|
69
|
Comparison of labetalol with other anti-hypertensive drugs.
|
Br J Clin Pharmacol
|
1982
|
0.78
|
|
70
|
A severe 'stasis eczema', associated with low plasma zinc, treated successfully with oral zinc.
|
Br J Dermatol
|
1981
|
0.78
|
|
71
|
Platelet function in patients with hypercholesterolaemia.
|
Eur J Clin Invest
|
1994
|
0.78
|
|
72
|
-Receptor antagonists in angina pectoris.
|
Ann Clin Res
|
1971
|
0.78
|
|
73
|
Plasma and platelet free catecholamine concentrations in patients with familial hypercholesterolaemia.
|
Clin Sci (Lond)
|
1992
|
0.78
|
|
74
|
Mechanism of the antihypertensive action of beta-adrenergic blocking drugs.
|
Cardiology
|
1980
|
0.78
|
|
75
|
Beta blockade and the effects of stress on the normal and ischaemic heart.
|
Aviat Space Environ Med
|
1981
|
0.78
|
|
76
|
Some major consequences of actions of drugs on the autonomic nervous system in man and experience of prediction from animal studies.
|
Pharmacol Ther B
|
1979
|
0.77
|
|
77
|
A within-patient comparison of bethanidine, methyldopa and propranolol in the treatment of hypertension.
|
Clin Sci Mol Med Suppl
|
1976
|
0.77
|
|
78
|
Platelet in vitro responses to urapidil and prazosin.
|
Drugs
|
1990
|
0.77
|
|
79
|
Clinical pharmacology of carvedilol.
|
Clin Investig
|
1992
|
0.77
|
|
80
|
Proceedings: Alpha-adrenoceptor inhibition from indoramin in man.
|
Br J Pharmacol
|
1972
|
0.76
|
|
81
|
Gastrointestinal haemorrhage associated with free-base (crack) cocaine.
|
Postgrad Med J
|
1995
|
0.76
|
|
82
|
Sympathomimetic amine infusion after beta-adrenoceptor and parasympathetic blockade [proceedings].
|
Br J Clin Pharmacol
|
1979
|
0.76
|
|
83
|
The management of hypertension.
|
Br J Clin Pharmacol
|
1986
|
0.75
|
|
84
|
Log dose-response curve to assess the effects of propranolol in angina pectoris.
|
Br J Pharmacol
|
1971
|
0.75
|
|
85
|
Alcoholism: prevention better than cure.
|
Br J Clin Pharmacol
|
1975
|
0.75
|
|
86
|
Letter: Misleading drug advertising.
|
Br Med J
|
1975
|
0.75
|
|
87
|
The acute exercise test for the preliminary evaluation of beta-receptor blocking drugs in angina pectoris.
|
Br J Pharmacol
|
1969
|
0.75
|
|
88
|
Beta-blockade and surgery.
|
Eur Heart J
|
2001
|
0.75
|
|
89
|
Collaborating with the pharmaceutical industry.
|
Br Med J
|
1979
|
0.75
|
|
90
|
The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjects.
|
Br J Clin Pharmacol
|
1995
|
0.75
|
|
91
|
Problems with Beta Adrenergic Blocking Drugs and other Antihypertensive Drugs.
|
Proc R Soc Med
|
1977
|
0.75
|
|
92
|
Obstructive sodium-losing nephropathy--a case report and review.
|
Postgrad Med J
|
1981
|
0.75
|
|
93
|
Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.
|
Br J Clin Pharmacol
|
1979
|
0.75
|
|
94
|
The combined effect of propranolol with bethanidine or methyldopa in hypertension.
|
Adv Clin Pharmacol
|
1976
|
0.75
|
|
95
|
Letter: Liquor licensing and public health.
|
Br Med J
|
1976
|
0.75
|
|
96
|
Hypotensive action from combination of propranolol and other hypotensive drugs.
|
Br J Pharmacol
|
1971
|
0.75
|
|
97
|
A log-dose-response study of xipamide and its effect on metabolic parameters.
|
J Hypertens Suppl
|
1989
|
0.75
|
|
98
|
Exercise testing in hypertensive patients.
|
JAMA
|
1984
|
0.75
|
|
99
|
An Examination of Some Factors which Influence the Stability of in Vitro Platelet Responses.
|
Platelets
|
1994
|
0.75
|
|
100
|
Long-term treatment of hypertension with labetalol.
|
Br J Clin Pharmacol
|
1979
|
0.75
|
|
101
|
Position of beta blockers in antihypertensive therapy.
|
J Cardiovasc Pharmacol
|
1986
|
0.75
|
|
102
|
Beta-adrenoceptor blocking drugs.
|
Practitioner
|
1977
|
0.75
|
|
103
|
The beta-adrenergic blockade withdrawal phenomenon.
|
J Pharmacol
|
1983
|
0.75
|
|
104
|
Propranol in hypertension.
|
Acta Cardiol
|
1972
|
0.75
|
|
105
|
Bromocriptine in the treatment of hypertension.
|
Eur J Clin Pharmacol
|
1986
|
0.75
|
|
106
|
Proceedings of the Second Symposium on Labetalol, London, March 1979.
|
Br J Clin Pharmacol
|
1979
|
0.75
|
|
107
|
[Withdrawal of preparations blocking beta-adrenergic receptors].
|
Ter Arkh
|
1982
|
0.75
|
|
108
|
Effects of noradrenaline infusion on platelet catecholamine levels and platelet aggregation.
|
J Hypertens Suppl
|
1989
|
0.75
|
|
109
|
The effect of urapidil on responses to phenylephrine, angiotensin and isoprenaline in man.
|
Eur J Clin Pharmacol
|
1991
|
0.75
|
|
110
|
Dilevalol: a dose-response study in normal volunteers.
|
J Hum Hypertens
|
1990
|
0.75
|
|
111
|
Collagen-induced Platelet Activation In Vitro Increases Plasma Catecholamine Concentration.
|
Platelets
|
1992
|
0.75
|
|
112
|
The development of the management of hypertension--have we now reached the ideal?
|
Trans Med Soc Lond
|
1993
|
0.75
|
|
113
|
Effect of food on the absorption of hydralazine in man.
|
Eur J Clin Pharmacol
|
1981
|
0.75
|
|
114
|
Pressor responses to beta-adrenergic-blocking drugs.
|
Lancet
|
1977
|
0.75
|
|
115
|
Beta-blocking agents.
|
Br J Hosp Med
|
1998
|
0.75
|
|
116
|
Discovery of the hypotensive effect of propranolol.
|
Postgrad Med J
|
1976
|
0.75
|
|
117
|
Platelet efflux of noradrenaline in patients with type 1 diabetes mellitus.
|
Clin Sci (Lond)
|
1989
|
0.75
|
|
118
|
In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
|
Br J Clin Pharmacol
|
1997
|
0.75
|
|
119
|
Hypertension. Current therapeutic practice reviewed.
|
Drugs
|
1986
|
0.75
|
|
120
|
[Anti-hypertensive agents].
|
Clin Ter
|
1969
|
0.75
|
|
121
|
Platelet noradrenaline release in patients with familial hypercholesterolaemia.
|
Eur J Clin Invest
|
1989
|
0.75
|
|
122
|
Variable dose comparative trial of propranolol and sotalol in angina pectoris.
|
Br Heart J
|
1973
|
0.75
|
|
123
|
The pharmacological basis for the use of labetalol in the treatment of hypertension.
|
J Cardiovasc Pharmacol
|
1981
|
0.75
|
|
124
|
Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.
|
Br J Clin Pharmacol
|
1979
|
0.75
|
|
125
|
Withdrawal of beta-blocking drugs.
|
Am Heart J
|
1982
|
0.75
|
|
126
|
An antihypertensive drug with polyfactor mechanism of action: urapidil.
|
Ann Fr Anesth Reanim
|
1989
|
0.75
|
|
127
|
Influence of the alpha-adrenoreceptor naftopidil and doxazosin, on adrenaline-induced serotonin platelets: comparison with the antagonists, collagen and efflux by human effects of nifedipine.
|
Platelets
|
1997
|
0.75
|
|
128
|
[Dose-effect test of Xipamid in hypertension as compared with other antihypertensive drugs].
|
Med Welt
|
1976
|
0.75
|
|
129
|
The effect of propranolol on the pressor response to exercise in coarctation of the aorta.
|
Curr Med Res Opin
|
1978
|
0.75
|